LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH L impact Sep 21, 2026, 10:58 AM UTC

Candel Therapeutics Price Target Raised to $18.00/Share From $12.00 by B of A Securities

Ratings actions

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

CADL

Related stories

Infosys Sets Q2 FY27 Earnings Announcement for October 23 Infosys will announce its Q2 FY27 results on Friday, October 23. The company's Board of Directors will convene on October 22 and 23 to approve the audited financial results for the M impact | EQUITY | Oct 06, 2026, 11:23 AM UTC S&P 500 Nears Record Highs on Tech Strength The S&P 500 is approaching its previous all-time closing high, driven by gains in the technology and energy sectors. Large-cap tech stocks like Nvidia, Apple, and Microsoft are sig M impact | EQUITY | Oct 06, 2026, 11:21 AM UTC MYR Group (MYRG.O) upgraded to buy from hold at Jefferies Jefferies raises rating on electrical contractor MYR Group to "buy" from "hold" as momentum builds and visibility improves across transmission and distribution/commercial and indus M impact | EQUITY | Oct 06, 2026, 11:20 AM UTC Edible Garden wins Walmart Thanksgiving-to-New Year fresh herb program Edible Garden was awarded a new Walmart fresh herb program for the Thanksgiving-through-New Year holiday season, adding incremental volume on top of existing distribution. L impact | EQUITY | Oct 06, 2026, 11:20 AM UTC CAC 40 Rises on Lower Bond Yields and Oil Prices French stocks climbed notably higher on Tuesday, rebounding from previous session's losses. Lower oil prices and bond yields helped lift sentiment. M impact | EQUITY | Oct 06, 2026, 11:17 AM UTC Spyre Therapeutics prices $350 mln follow-on share sale Shares of Spyre Therapeutics were down 4.1% premarket after the biotech firm priced a $350 million follow-on share offering at $85 per share, an 8.3% discount to the last sale. M impact | EQUITY | Oct 06, 2026, 11:16 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.